OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for OROPHARYNGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OROPHARYNGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for OROPHARYNGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a Two-Drug punch before surgery shrink head & neck tumors?
Disease control Recruiting nowThis study tests whether adding an experimental drug (CDX-1140) to a standard immunotherapy (cemiplimab) before surgery can shrink advanced head and neck cancers more than the immunotherapy alone. About 44 people with stage III-IV head and neck cancer will receive either the comb…
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could less radiation be just as effective for HPV+ throat cancer?
Disease control Recruiting nowThis study is testing whether a lower dose of radiation (30 Gy) can safely treat HPV-positive oropharyngeal cancer while reducing side effects. About 31 adults with this type of throat cancer will receive the reduced radiation along with standard chemotherapy. The main goal is to…
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Sara Medek • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug aims to supercharge immune system against HPV throat cancer
Disease control Recruiting nowThis study tests an experimental drug called CUE-101 in 30 people with HPV16-positive throat cancer. The drug is given before standard treatments like surgery or chemoradiation to see if it safely boosts the body's immune cells to fight the cancer. Researchers will monitor side e…
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could less radiation be safer? new trial aims to cut side effects after head and neck cancer surgery
Disease control Recruiting nowThis phase II trial tests whether a personalized, reduced-volume radiation plan can safely lower side effects after surgery for head and neck cancer. About 50 patients will receive radiation only to high-risk areas, skipping some traditionally treated zones. The goal is to see if…
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Olgun Elicin • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could less radiation be enough for HPV throat cancer?
Disease control Recruiting nowThis study is testing whether giving less radiation, based on a patient's HPV type and levels of HPV DNA in the blood, can control throat cancer as well as standard higher doses. About 250 adults with favorable-prognosis oropharyngeal cancer will receive 70, 60, or 50 gray of rad…
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo aims to shrink radiation damage in head and neck cancer
Disease control Recruiting nowThis study tests two ideas at once: adding a drug called ATRA (Vesanoid) to standard treatment, and using a smaller radiation area that targets the tumor more precisely. It includes 460 adults with certain types of head and neck cancer that haven't spread across the midline. The …
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Blood test may allow safer, Lower-Dose radiation for throat cancer patients
Disease control Recruiting nowThis study tests whether a blood test that detects HPV DNA can guide doctors to safely use a lower dose of radiation for people with HPV-related throat cancer. About 45 adults with early-stage HPV-positive oropharyngeal cancer will receive radiation and chemotherapy. The goal is …
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Less radiation, same control? new trial aims to boost quality of life for throat cancer patients
Disease control Recruiting nowThis study tests whether a shorter, lower-dose course of radiation after robotic surgery can improve quality of life for people with HPV-related throat cancer. About 42 adults who have had robotic surgery will receive a reduced radiation schedule. The goal is to see if this appro…
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Smarter radiation for head & neck cancer: Biopsy-Guided treatment may spare patients from dry mouth
Disease control Recruiting nowThis phase 3 trial tests whether using a sentinel lymph node biopsy to guide radiation can safely reduce the amount of neck radiation in people with certain head and neck cancers. The goal is to lower long-term side effects like severe dry mouth while still controlling the cancer…
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New skin flap could reduce surgery side effects for head and neck cancer patients
Disease control Recruiting nowThis study tests a new surgical technique using a thin skin flap from the groin area to rebuild the mouth or throat after cancer removal. The goal is to see if it causes fewer problems at the donor site compared to standard flaps. Forty adults with head and neck cancer will be fo…
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 26, 2026 17:27 UTC
-
New PET scan aims to spot hidden scar tissue
Diagnosis Recruiting nowThis study tests a special PET/CT scan that uses a tracer called FAPI-74 to find fibrosis (scar-like tissue) in the body. It includes 45 adults with conditions like head and neck cancer or tuberculosis that can cause fibrosis. The goal is to see how well the scan shows fibrosis, …
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
Simple mouth swab could spot hidden throat cancer early
Diagnosis Recruiting nowThis study is testing whether a simple mouth rinse can detect HPV-related throat cancer early, before symptoms appear. Researchers will compare results from 200 people with throat cancer and 200 healthy volunteers matched by age, sex, and background. If accurate, this test could …
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
Could a quicker CT scan replace MRI for oral cancer staging?
Diagnosis Recruiting nowThis study tests whether a special type of CT scan (dual-energy CT) can be as good as MRI for staging oral and throat cancers. Staging helps doctors decide the best treatment. If the CT works just as well, patients might avoid an extra MRI, get treated faster, and free up MRI mac…
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Sponsor: University Hospital, Strasbourg, France • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
New drug aims to ease painful mouth sores for head and neck cancer patients
Symptom relief Recruiting nowThis phase II trial tests whether adding BMX-001 to standard symptom management can reduce severe mouth sores in head and neck cancer patients receiving chemoradiation. About 98 participants will receive either BMX-001 or a placebo alongside usual care. The goal is to see if BMX-…
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Robotic surgery plus daily swallowing therapy aims to keep head and neck cancer patients eating and speaking normally
Symptom relief Recruiting nowThis study tests whether a personalized 12-week speech, swallowing, and voice rehabilitation program can help preserve swallowing function in head and neck cancer patients after minimally invasive robotic surgery. About 53 participants will be enrolled, including those having sur…
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Christian Simon • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Can a single injection ease pain and help swallowing after robotic throat surgery?
Symptom relief Recruiting nowThis study tests whether injecting a long-lasting local anesthetic called EXPAREL (liposomal bupivacaine) into the surgical wound can improve pain control and swallowing function in 80 adults undergoing robotic surgery for throat cancer. Participants will be compared to those who…
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Sponsor: Geisinger Clinic • Aim: Symptom relief
Last updated Jun 26, 2026 14:36 UTC
-
HIV and oral cancer: what blocks access to care?
Knowledge-focused Recruiting nowThis study talks to people living with HIV from diverse backgrounds to learn what helps or hinders them from getting oral health care and cancer prevention. Researchers will hold focus groups and use questionnaires to understand barriers and gather ideas for improvement. The goal…
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Blood test may predict throat cancer comeback
Knowledge-focused Recruiting nowThis study looks at 220 people with HPV-related oropharynx cancer to see if certain gene mutations (TRAF3 and CYLD) and levels of HPV DNA in the blood can predict if the cancer will come back after treatment. Participants give blood samples and fill out quality-of-life questionna…
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Remote hearing tests could save cancer Patients' hearing
Knowledge-focused Recruiting nowThis study tests whether offering hearing tests close to home or remotely increases how many head and neck cancer patients get their hearing checked during treatment. Many patients on cisplatin chemotherapy or radiation near the ear can lose hearing, but not all complete recommen…
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Simple test for throat cancer on the horizon?
Knowledge-focused Recruiting nowThis study from Mayo Clinic aims to find biological markers (biomarkers) in blood, tissue, and saliva that can signal the presence or absence of HPV-related oropharyngeal cancer. Researchers will follow 560 participants, including patients with and without the disease, to see if …
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Blood test could revolutionize throat cancer monitoring
Knowledge-focused Recruiting nowThis study is testing a blood test that looks for tiny pieces of cancer DNA in the bloodstream of people with throat cancer. The goal is to see if this test can track how well treatment is working and spot if the cancer comes back earlier than current methods. Researchers will co…
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Taiwan launches genetic mapping study for throat cancer
Knowledge-focused Recruiting nowThis study aims to collect and analyze genetic information from 300 Taiwanese patients with oropharyngeal cancer. Researchers will use advanced DNA sequencing to find genetic changes linked to the disease. The goal is to improve understanding and help design future treatments or …
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Sponsor: National Health Research Institutes, Taiwan • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
New imaging study aims to spot radiation damage to neck arteries
Knowledge-focused Recruiting nowThis study looks at how radiation therapy for head and neck cancers affects the blood vessels in the neck. Researchers will use two types of PET/CT scans to compare images taken before and after treatment. The goal is to better understand and detect radiation-related vascular dam…
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC